Randomized Controlled Trial of Paliperidone Extended Release Versus Risperidone for the Treatment of Methamphetamine-Associated Psychosis in Chinese Patients

BACKGROUND: The efficacy or tolerability of paliperidone extended release (ER) in the treatment of methamphetamine (METH)-associated psychosis (MAP) is unknown. This study was designed to assess the tolerability and efficacy of paliperidone ER and risperidone for the treatment of MAP in China. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Gang, Ding, Fan, Chawarski, Marek Cezary, Hao, Wei, Liu, Xuebing, Deng, Qijian, Ouyang, Xuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141424/
https://www.ncbi.nlm.nih.gov/pubmed/32296355
http://dx.doi.org/10.3389/fpsyt.2020.00237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141424/
https://www.ncbi.nlm.nih.gov/pubmed/32296355
http://dx.doi.org/10.3389/fpsyt.2020.00237

Ejemplares similares